The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 16,001–16,100 of 31,469
Calderón-DuPont, D., Torre-Villalvazo, I., & Díaz‐Villaseñor, A. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.021 · Cited by 23
Hosni, A., Abdel‐Moneim, A., Hussien, M., Zanaty, M. I., Eldin, Z. E., & El‐Shahawy, A. A. G. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.048 · Cited by 21
Cao, Q., Zheng, R., He, R., Wang, T., Xu, M., Lu, J., Dai, M., Zhang, D., Chen, Y., Zhao, Z., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-14555-1 · Cited by 21
El-Eshmawy, M. M., Ibrahim, A. A. E. W., Bahriz, R., Shams-Eldin, N., & Mahsoub, N. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01240-y · Cited by 19
Ong, Y. Y., Pang, W. W., Michael, N., Aris, I. M., Sadananthan, S. A., Tint, M., Choo, J. T. L., Ling, L. H., Karnani, N., Velan, S. S., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2022.10.021 · Cited by 22
Belany, P. A., Kackley, M. L., Zhao, S., Kluwe, B., Buga, A., Crabtree, C. D., Nedungadi, D., Kline, D., Brock, G. N., Simonetti, O. P., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad009 · Cited by 17
Preconception Vitamin D Level and In Vitro Fertilization: Pregnancy Outcome
Hasan, H. A., Barber, T. M., Cheaib, S., et al. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.01.005 · Cited by 18
Simpson, E. J., Mendis, B., Dunlop, M. V., Schroeter, H., Kwik-Uribe, C. L., & Macdonald, I. A. (2023) · Nutrients · doi:10.3390/nu15030565 · Cited by 18
Berezin, A. A., Obradovic, Z., Fushtey, I. M., Berezina, T. A., Novikov, E. V., Schmidbauer, L., Lichtenauer, M., & Berezin, A. Е. (2023) · Biomedicines · doi:10.3390/biomedicines11020457 · Cited by 19
Treatment with bergamot (Citrus bergamia) leaves extract attenuates leptin resistance in obese rats
Nakandakare-Maia, E. T., Siqueira, J. S., Ferron, A. J. T., Vieira, T. A., Palacio, T. L. N., Grandini, N. A., Garcia, J. L., Belin, M. A. F., Altomare, A., Baron, G., et al. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111908 · Cited by 20
Shahid, R. K., Chu, L. M., Arnason, T., & Pahwa, P. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.03.006 · Cited by 21
Wang, H., Shen, Q., Zhang, F., Fu, Y., Zhu, Y., Zhao, L., Wang, C., & Zhao, Q. (2023) · Food & Function · doi:10.1039/d3fo00294b · Cited by 19
Barnett, B. G., Wesselowski, S. R., Gordon, S. G., Saunders, A. B., Promislow, D., Schwartz, S. M., Chou, L., Evans, J. B., Kaeberlein, M. R., & Creevy, K. E. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1168711 · Cited by 17
Maldonado, F. H. R., Mega, P. F., Germano, C. W., Dias, L. L. C., Callejas, G. H., Gestic, M. A., Utrini, M. P., Chaim, F. D. M., Callejas-Neto, F., Chaim, É. A., et al. (2023) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2022.0663.r1.24042023 · Cited by 18
Waist-to-height ratio associated cardiometabolic risk phenotype in children with overweight/obesity
Ukegbu, T. E., Wylie‐Rosett, J., Groisman-Perelstein, A. E., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-16418-9 · Cited by 18
Azab, E. F. E., Alakilli, S. Y. M., Saleh, A. M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813759 · Cited by 18
Rania, M., Caroleo, M., Carbone, E. A., Ricchio, M., Pelle, M. C., Zaffina, I., Condoleo, F., de Filippis, R., Aloi, M., Fazio, P. D., et al. (2023) · Journal of Eating Disorders · doi:10.1186/s40337-023-00891-z · Cited by 21
Shehnaz, S. I., Roy, A., Vijayaraghavan, R., Sivanesan, S., & Pazhanivel, N. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08804-8 · Cited by 18
Zelows, M. M., Cady, C., Dharanipragada, N., Mead, A. E., Kipp, Z. A., Bates, E. A., Varadharajan, V., Banerjee, R., Park, S., Shelman, N. R., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101815 · Cited by 18
Nijssen, K. M. R., Mensink, R. P., Plat, J., Ivanov, D., Preissl, H. T., & Joris, P. J. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.12.010 · Cited by 19
Rasouli, N., Younes, N., Ghosh, A., Albu, J., Cohen, R. M., DeFronzo, R. A., Diaz, E., Kassem, L. S., Luchsinger, J. A., McGill, J. B., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1070 · Cited by 20
Armandi, A., Bespaljko, H., Mang, A., Huber, Y., Michel, M. S., Labenz, C., Galle, P. R., Neerukonda, M., Bugianesi, E., Schuppan, D., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17941 · Cited by 18
Niyazi, A., Yasrebi, S. M. A., Yazdanian, M., & Rahimi, G. R. M. (2024) · Biological Research For Nursing · doi:10.1177/10998004241239330 · Cited by 20
Öztürk, D., Sivaslioglu, A., Buluş, H., et al. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.03.004 · Cited by 18
Dai, D., Kong, F., Han, H., et al. (2024) · Journal of Dairy Science · doi:10.3168/jds.2023-24435 · Cited by 18
Cho, Y. K., Kim, K. S., Lee, B., Hong, J. H., Yu, J. M., Lim, S. K., Kim, Y. A., Lee, C. B., Kim, S. S., Kwak, S. H., et al. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.06.023 · Cited by 18
Monacelli, F., Borghi, R., Cammarata, S., Nencioni, A., Piccini, A., Tabaton, M., & Odetti, P. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142511 · Cited by 18
Vogt, B. P., Souza, P. L., Minicucci, M. F., Martín, L. C., Barretti, P., & Caramori, J. C. T. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0011 · Cited by 18
Ouchi, M., Suzuki, T., Hashimoto, M., Motoyama, M., Ohara, M., Suzuki, K., Igari, Y., Watanabe, K., Nakano, H., & Oba, K. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21549 · Cited by 18
Antonini‐Canterin, F., Mateescu, A. D., Vriz, O., Carrubba, S. L., Bello, V. D., Carerj, S., Zito, C., Sparacino, L., Marzano, B., Uşurelu, C., et al. (2013) · Cardiology · doi:10.1159/000355260 · Cited by 18
Saad, V., Wicklow, B. A., Wittmeier, K. D. M., Hay, J. L., MacIntosh, A., Venugopal, N., Ryner, L. N., Berard, L., & McGavock, J. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0465-x · Cited by 18
Glycated apolipoprotein B—A surrogate marker of subclinical atherosclerosis
Dev, K., Sharma, S. B., Garg, S., et al. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.09.012 · Cited by 18
ORTEGA, J. F., Fernández-Elías, V. E., Hamouti, N., & Mora‐Rodríguez, R. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0123 · Cited by 20
Delayed clearance of triglyceride‐rich lipoproteins in young, healthy obese subjects
Larsen, M. A., Goll, R., Lekahl, S., Moen, O. S., & Florholmen, J. R. (2015) · Clinical Obesity · doi:10.1111/cob.12118 · Cited by 18
Travers, R. L., Motta, A. C., Betts, J. A., & Thompson, D. (2015) · Zeitschrift für Ernährungswissenschaft · doi:10.1007/s00394-015-1087-7 · Cited by 18
Menezes, C. N., Crowther, N. J., Duarte, R., Amsterdam, D. V., Evans, D. H., Dickens, C., Dix‐Peek, T., Rassool, M. S., Prinsloo, A. S., Raal, F. J., et al. (2013) · HIV Medicine · doi:10.1111/hiv.12074 · Cited by 17
Lee, J., Ryoo, J., Choi, J., & Park, S. K. (2014) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.14.028 · Cited by 18
Park, J., Kim, S., Park, S., et al. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00199.x · Cited by 18
Petta, S., Maida, M. F., Grimaudo, S., Pipitone, R. M., Macaluso, F. S., Cabibi, D., Cammà, C., Marco, V. D., Sferrazza, S., & Craxı̀, A. (2015) · Liver International · doi:10.1111/liv.12918 · Cited by 18
Martínez‐Larrad, M. T., Lorenzo, C., González‐Villalpando, C., Gabriel, R., Haffner, S. M., & Serrano‐Ríos, M. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03723.x · Cited by 18
Insulin resistance in euglycemic cirrhosis.
Goswami, A., Bhargava, N., Dadhich, S., et al. (2014) · PubMed · Cited by 18
Meshkani, R., Saberi, H., Mohammadtaghvaei, N., & Tabatabaiefar, M. A. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1017-9 · Cited by 18
Güneş, Ö., Taşçılar, E., Sertoğlu, E., Taş, A., Serdar, M. A., Kaya, G., Kayadibi, H., & Özcan, O. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.09.006 · Cited by 18
Healy, S. J., Osei, K., & Gaillard, T. R. (2014) · Diabetes Care · doi:10.2337/dc14-1803 · Cited by 18
Barseem, N. F., & Helwa, M. A. (2015) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2014.12.001 · Cited by 18
Clarenbach, J. J., Vega, G. L., ADAMS-HUET, B. A., Considine, R. V., Ricks, M., & Sumner, A. E. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.07001 · Cited by 18
Retinol-Binding Protein 4 Levels in Obese Children and Adolescents with Glucose Intolerance
Yeste, D., Vendrell, J. J., Tomasini, R., Gallart, L., Clemente, M., Simón, I., Albisu, M., Gussinyé, M., Audí, L., & Carrascosa, A. (2010) · Hormone Research in Paediatrics · doi:10.1159/000308165 · Cited by 18
Hepatic steatosis in overweight/obese females: Newscreening method for those at risk
Tarantino, G., Pizza, G., Colao, A., Pasanisi, F., Conca, P., Colicchio, P., Finelli, C., Contaldo, F., Somma, C. D., & Savastano, S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5693 · Cited by 18
Goldfine, A. B., Gerwien, R. W., Kolberg, J. A., O'Shea, S., Hamren, S., Hein, G. P., Xu, X. M., & Patti, M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.156133 · Cited by 18
Franzon, K., Zethelius, B., Cederholm, T., & Kilander, L. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13352 · Cited by 20
Lupattelli, G., VUONO, S. D., Boni, M., Helou, R. S., Mannarino, M. R., Roscini, A. R., Alaeddin, A., Pirro, M., & Vaudo, G. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.18663 · Cited by 18
Şengül, C., Özveren, O., Duman, D., Eroğlu, E., Oduncu, V., Tanboğa, İ. H., Can, M. M., Akgün, T., & Dindar, İ. (2011) · Blood Pressure · doi:10.3109/08037051.2011.569992 · Cited by 19
Lan, J., Chen, X., Chen, X., Wang, S., Zhang, X., Wu, K., He, S., Peng, Y., Jiang, L., Li, L., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.039 · Cited by 18
Padmaja, T. K., Naidu, P. B., Kumar, G. E. N. H., Ganapathy, S., & Meriga, B. (2014) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2014.511101 · Cited by 20
Nutrition Status of Patients With Chronic Hepatitis B or C
Menta, P. L. D. R., Correia, M. I. T. D., Vidigal, P. V. T., et al. (2014) · Nutrition in Clinical Practice · doi:10.1177/0884533614546168 · Cited by 18
Qu, H., Li, Q., Grove, M. L., Yang, L., Pan, J., Rentfro, A. R., Bickel, P. E., Fallon, M. B., Hanis, C. L., Boerwinkle, E., et al. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.08.005 · Cited by 18
Functional and Morphological Changes in Endocrine Pancreas following Cola Drink Consumption in Rats
Losada, M. E. O., Cao, G., González, J., Müller, A., Ottaviano, G., Lillig, C. H., Capani, F., Ambrosio, G., & Milei, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118700 · Cited by 18
Prudente, S., Baratta, R., Andreozzi, F., Morini, E., Farina, M. G., Nigro, A., Copetti, M., Pellegrini, F., Succurro, E., di Pietrantonio, L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1749-1 · Cited by 18
Jetha, M., Nzekwu, U., Lewanczuk, R. Z., & Ball, G. (2009) · Journal of Pediatric Endocrinology & Metabolism (JPEM) · doi:10.1515/jpem.2009.22.11.1051 · Cited by 21
Bona, K. S. D., Bonfanti, G., Bitencourt, P. E. R., et al. (2013) · Inflammation · doi:10.1007/s10753-013-9697-9 · Cited by 18
Dabelea, D., Ma, Y., Knowler, W. C., Marcovina, S. M., Saudek, C. D., Arakaki, R., White, N. H., Kahn, S. E., Orchard, T. J., Goldberg, R. B., et al. (2014) · Diabetic Medicine · doi:10.1111/dme.12437 · Cited by 18
Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?
Paschou, S. Α., Ioannidis, D., Vassilatou, E., Mizamtsidi, M., Panagou, M., Lilis, D., Tzavara, I., & Vryonidou, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122050 · Cited by 17
Influence of age on leptin induced skeletal muscle signalling
Guadalupe‐Grau, A., Larsen, S., Guerra, B., Calbet, J. A. L., Dela, F., & Helge, J. W. (2014) · Acta Physiologica · doi:10.1111/apha.12273 · Cited by 18
Schwarz, H., Birkholz-Walerzak, D., Szalecki, M., Walczak, M., Găleşanu, C., Metreveli, D., Khan-Boluki, J., & Schuck, E. (2014) · Biologics in Therapy · doi:10.1007/s13554-014-0014-4 · Cited by 18
Subash‐Babu, P., Ignacimuthu, S., & Agastian, P. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.12.004 · Cited by 18
Ramírez-Salazar, M., Pérez-Luque, E. L., Fajardo-Araujo, M. E., Martı́nez-Garza, S., & Malacara, J. M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31816d5b2d · Cited by 18
Henderson, M., Baillargeon, J., RABASA-LHORET, R. P. R., Chiasson, J. L., Hanley, J., & Lambert, M. A. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.02.002 · Cited by 18
The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity
Arias, N., Macarulla, M. T., Aguirre, L., Martínez-Castaño, M. G., Gómez‐Zorita, S., Miranda, J., Martínez, J. A., & Portillo, M. P. (2011) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-011-0086-2 · Cited by 18
Cho, S.-J., Park, H.-J., Jung, U. J., Kim, H., Moon, B. S., & Choi, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151017778 · Cited by 20
Miyazaki, Y., Akasaka, H., Ohnishi, T., Saitoh, S., DeFronzo, R. A., & Shimamoto, K. (2008) · Hypertension Research · doi:10.1291/hypres.31.1357 · Cited by 18
Carillon, J., Knabe, L., Montalban, A., Stévant, M., Kéophiphath, M., Lacan, D., Cristol, J., & Rouanet, J. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300466 · Cited by 18
Liatis, S., Sfikakis, P. P., Tsiakou, A. G., Stathi, C., Terpos, E., Katsilambros, N. L., & Makrilakis, K. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.01.001 · Cited by 18
Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kandaraki, E., Tsourdi, E. A., Mavridis, S., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0023 · Cited by 18
Effects of a hypercaloric diet on β‐cell responsivity in lean healthy men
Brands, M., Swat, M. J., Lammers, N. M., Sauerwein, H. P., Endert, E., Ackermans, M. T., Verhoeven, A. J., & Serlie, M. J. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04364.x · Cited by 18
Bracale, R., Petroni, M. L., Davinelli, S., Bracale, U. M., Scapagnini, G., Carruba, M. O., & Nisoli, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098244 · Cited by 18
Circulating Vascular Progenitor Cells and Central Arterial Stiffness in Polycystic Ovary Syndrome
Dessapt-Baradez, C., Reza, M., Sivakumar, G. S., Hernández-Fuentes, M. P., Markakis, K., Gnudi, L., & Karalliedde, J. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020317 · Cited by 18
Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV
Dirajlal‐Fargo, S., Kinley, B., Jiang, Y., Longenecker, C. T., Hileman, C. O., Debanne, S. M., & McComsey, G. A. (2014) · AIDS · doi:10.1097/qad.0000000000000547 · Cited by 18
Buettner, R., Ottinger, I., Gerhardt-Salbert, C., Wrede, C. E., Schölmerich, J., & Bollheimer, L. C. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00263.2006 · Cited by 18
Serum Phosphate, Blood Pressure, and the Metabolic Syndrome—20‐Year Follow‐Up of Middle‐Aged Men
Gudmundsdottir, H., Strand, A. H., Kjeldsen, S. E., Høieggen, A., & Os, I. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00032.x · Cited by 18
Beta-cell function is associated with metabolic syndrome in Mexican subjects
Pérez-Fuentes, R. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s12375 · Cited by 18
Nakhjavani, M., Karimi-Jafari, H., Esteghamati, A., Khalilzadeh, O., Asgarani, F., & Ghadiri‐Anari, A. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2010.02.026 · Cited by 18
El-Karaksy, H. M., El‐Raziky, M. S., Fouad, H. M., Anwar, G. M., El‐Mougy, F., El-Koofy, N. M., & El-Hennawy, A. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.10.008 · Cited by 18
Adiposity indices in the prediction of insulin resistance in prepubertal Colombian children
Mueller, N. T., Pereira, M. A., Buitrago-López, A., Rodríguez, D., Durán, Á. E., Ruiz, Á. J., Rueda‐Clausen, C. F., & Villa‐Roel, C. (2012) · Public Health Nutrition · doi:10.1017/s136898001200393x · Cited by 18
Obstructive Sleep Apnea and Obesity are Associated With Reduced GPR 120 Plasma Levels in Children
Gozal, D., Gozal, D., Carreras, A., Khalyfa, A., & Peris, E. (2014) · SLEEP · doi:10.5665/sleep.3664 · Cited by 18
Jaakkola, U.-M., Kakko, T., Seppälä, H., et al. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.07.010 · Cited by 18
Varvel, S. A., Vörös, S., Thiselton, D. L., Pottala, J. V., Dall, T., Warnick, G. R., McConnell, J. P., Ghaedi, L., Sasinowski, M., & Graham, T. E. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9577-1 · Cited by 18
Jürimäe, J., Kums, T., & Jürimäe, T. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1423-9 · Cited by 18
Yan, J. Y., Hu, C., Jiang, F., Zhang, R., Wang, J., Tang, S., Peng, D., Chen, M., Bao, Y., & Jia, W. (2014) · Diabetic Medicine · doi:10.1111/dme.12587 · Cited by 18
Khanal, R. C., Howard, L. R., Wilkes, S. E., Rogers, T. J., & Prior, R. L. (2010) · Journal of Functional Foods · doi:10.1016/j.jff.2010.11.003 · Cited by 18
Atwa, M. A., Emara, A., Balata, M. G., Youssef, N., Bayoumy, N. M. K., Sherif, A., & Fiala, L. (2013) · International Journal of Dermatology · doi:10.1111/ijd.12340 · Cited by 18
Yoh, J., Nishi, Y., Hosoda, H., Tajiri, Y., Yamada, K., Yanase, T., Doi, R., Yonemoto, K., Kangawa, K., Kojima, M., et al. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2010.12.010 · Cited by 18
Tangvarasittichai, S., Pongthaisong, S., Meemark, S., & Tangvarasittichai, O. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0443-3 · Cited by 18
Venkataraman, K., Khoo, C. M., Leow, M. K., Khoo, E. Y. H., Isaac, V., Zagorodnov, V., Sadananthan, S. A., Velan, S. S., Chong, Y. S., Gluckman, P. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074410 · Cited by 18
Uçar, A., Öz, F., Baş, F., Oflaz, H., Nişli, K., Tuğrul, M., Yetim, A., Darendelıler, F., Saka, N., Poyrazoğlu, Ş., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12626 · Cited by 18
Chang, C. J., Liou, S., Tzeng, T., & Liu, I.-M. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.11.048 · Cited by 19
Maraki, M. I., Christodoulou, N., Aggelopoulou, N., Magkos, F., Skenderi, K., Panagiotakos, D. B., Kavouras, S. A., & Sidossis, L. S. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508012233 · Cited by 18
Leptin Is Associated with Mood Status and Metabolic Homeostasis in Patients with Bipolar Disorder
Lee, H. J., Kim, S. H., Kim, E. Y., Lee, N. Y., Yu, H. Y., Kim, Y. S., & Ahn, Y. M. (2014) · Neuropsychobiology · doi:10.1159/000366488 · Cited by 18
Correlation of insulin resistance by various methods with fasting insulin in obese
Goyal, G., Panag, K. M. S., & Kaur, N. (2014) · International Journal of Applied and Basic Medical Research · doi:10.4103/2229-516x.140733 · Cited by 18
Biswas, M., Hampton, D., Turkes, A., Newcombe, R. G., & Rees, A. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03824.x · Cited by 18
Effects of canrenone in patients with metabolic syndrome
Derosa, G., Bonaventura, A., Bianchi, L., Romano, D., D’Angelo, A., Fogari, E., & Maffioli, P. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.832756 · Cited by 18
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
